Background: The plant kingdom represents an unlimited source of phytotherapeutics with promising perspectives in the field of anticancer drug discovery. Purpose: In this view, epithelial-mesenchymal transition (EMT) represents a novel and major target in anticancer therapy. Therefore, this narrative review aims to provide an updated overview on the bioactive phytochemicals with anti-EMT activity. Conclusion: Among the plant products reviewed, phenylpropanoids were the most investigated at preclinical phase, thus exhibiting a promising potential as anticancer drugs, though an evidence-based clinical efficacy is still lacking.
Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis / B. Salehi, E.M. Varoni, M. Sharifi-Rad, S. Rajabi, P. Zucca, M. Iriti, J. Sharifi-Rad. - In: PHYTOMEDICINE. - ISSN 0944-7113. - 55(2019 Mar 01), pp. 125-136.
Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis
E.M. Varoni;M. Iriti;
2019
Abstract
Background: The plant kingdom represents an unlimited source of phytotherapeutics with promising perspectives in the field of anticancer drug discovery. Purpose: In this view, epithelial-mesenchymal transition (EMT) represents a novel and major target in anticancer therapy. Therefore, this narrative review aims to provide an updated overview on the bioactive phytochemicals with anti-EMT activity. Conclusion: Among the plant products reviewed, phenylpropanoids were the most investigated at preclinical phase, thus exhibiting a promising potential as anticancer drugs, though an evidence-based clinical efficacy is still lacking.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0944711318302538-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.78 MB
Formato
Adobe PDF
|
1.78 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.